7 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Guideline for the Management ... Task Force on Clinical ... Society of America #HFrEF ... #CHF #guideline
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
recommended by the ACC ... /ambcarerx #CHF ... #HFrEF #Pharmacology ... #Management #Treatment ... #StageC #Cardiology
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
) Clinical Presentation ... endomyocardial biopsy Pharmacology ... : • ACE Inhibitors ... heartfailure #diagnosis #management ... #cardiology #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Skin exam for infection ... disease b) CHF ... Change in clinical ... one post op Cardiology ... medical and surgical management
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
Therapy: • Perform CSF ... consultation to guide management ... Neurosyphilis, Otic, or Ocular ... #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
as substantial clinical ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
HIV-infected persons with clinical ... recommended for all ... Prevention #Treatment #management ... #opportunistic ... #pharmacology